Daniel Markowitz CFA
Stock Analyst at Evercore ISI
(4.57)
# 970
Out of 5,023 analysts
65
Total ratings
62.2%
Success rate
30.4%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFLY Butterfly Network | Initiated Coverage: Buy | $15 | $8.95 | +67.60% | 1 | Sep 29, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $20 → $27 | $19.70 | +37.06% | 4 | Sep 2, 2026 | |
| NTRA Natera | Reiterated: Buy | $300 → $360 | $410.35 | -12.27% | 9 | Aug 7, 2026 | |
| PODD Insulet | Reiterated: Buy | $180 | $131.69 | +36.68% | 6 | Aug 6, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $40 → $54 | $69.97 | -22.82% | 9 | Aug 4, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $410 → $425 | $364.98 | +16.44% | 10 | Jul 27, 2026 | |
| RGEN Repligen | Reiterated: Buy | $140 → $160 | $181.70 | -11.94% | 9 | Jul 6, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $118 → $90 | $79.80 | +12.79% | 6 | Jul 6, 2026 | |
| TECH Bio-Techne | Rated: Hold | $54 → $50 | $72.40 | -30.94% | 6 | May 7, 2026 | |
| DXCM DexCom | Initiated Coverage: Hold | $68 | $85.36 | -20.34% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $90 | $177.80 | -49.38% | 4 | Oct 30, 2025 |
Butterfly Network
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $8.95
Upside: +67.60%
MiniMed Group
Sep 2, 2026
Reiterated: Buy
Price Target: $20 → $27
Current: $19.70
Upside: +37.06%
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $300 → $360
Current: $410.35
Upside: -12.27%
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $180
Current: $131.69
Upside: +36.68%
Inspire Medical Systems
Aug 4, 2026
Reiterated: Hold
Price Target: $40 → $54
Current: $69.97
Upside: -22.82%
West Pharmaceutical Services
Jul 27, 2026
Reiterated: Buy
Price Target: $410 → $425
Current: $364.98
Upside: +16.44%
Repligen
Jul 6, 2026
Reiterated: Buy
Price Target: $140 → $160
Current: $181.70
Upside: -11.94%
TransMedics Group
Jul 6, 2026
Reiterated: Buy
Price Target: $118 → $90
Current: $79.80
Upside: +12.79%
Bio-Techne
May 7, 2026
Rated: Hold
Price Target: $54 → $50
Current: $72.40
Upside: -30.94%
DexCom
Nov 26, 2025
Initiated Coverage: Hold
Price Target: $68
Current: $85.36
Upside: -20.34%
Oct 30, 2025
Reiterated: Buy
Price Target: $68 → $90
Current: $177.80
Upside: -49.38%